Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.